Frederick Funke, MD
Cardiovascular Disease · Ladson, SCNPI 1437357274
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 530 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,953 and has fallen 67.6% since, to $633 in 2025.
Across 530 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$1K
- Medtronic$930
- E.r. Squibb & Sons, L.L.C.$683
- AstraZeneca$663
- Inari Medical, Inc.$534
- plus $5K from 33 others
Across 8 payments — averaging $16,580 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$133K
What the payments were for
- Food & beverage$10,533100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 78 | $1,679 |
| Boston Scientific | 48 | $1,145 |
| Medtronic(2 entities) | 50 | $930 |
| E.r. Squibb & Sons, L.L.C. | 47 | $683 |
| AstraZeneca | 44 | $663 |
| Inari Medical, Inc. | 2 | $534 |
| Boehringer Ingelheim | 25 | $465 |
| Cardiva Medical, Inc. | 30 | $461 |
| Philips North America LLC | 12 | $449 |
| Novartis | 23 | $389 |
| Amgen | 28 | $352 |
| Johnson & Johnson | 25 | $351 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $312 |
| Pfizer | 17 | $283 |
| Merck | 11 | $164 |
| Abiomed | 1 | $143 |
| Livanova USA, Inc. | 1 | $133 |
| Endologix LLC | 2 | $122 |
| Teleflex LLC | 4 | $117 |
| Astellas Pharma US Inc | 6 | $114 |
| Edwards Lifesciences | 5 | $113 |
| Biotronik Inc. | 6 | $102 |
| Alnylam Pharmaceuticals Inc. | 5 | $99 |
| Irhythm Technologies, Inc. | 3 | $90 |
| Regeneron Healthcare Solutions, Inc. | 6 | $87 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $75 |
| Esperion Therapeutics, Inc. | 5 | $74 |
| Lexicon Pharmaceuticals, Inc. | 4 | $70 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $60 |
| Cvrx, Inc. | 3 | $52 |
| Scpharmaceuticals Inc. | 2 | $39 |
| Heartflow, Inc. | 1 | $36 |
| Atricure, Inc. | 1 | $23 |
| Shockwave Medical, Inc | 1 | $19 |
| Preventice Services, LLC | 1 | $18 |
| Bayer | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FlowTriever$534
- ClotTriever$534
- Confirm Rx$250
- SYNERGY$150
- AVEIR$144
- Impella$143
- TandemLife$133
- Watchman$125
- Quadra Assura CRT Defibrillator$125
- AVVIGO Guidance System$123
- Ovation iX Iliac Stent Graft$120
- AFX2 Bifurcated Endograft System$120
How this compares
$10,567 in reported general payments places this provider in the 80th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 195 | $210,792 |
| EntrestoSacubitril/Valsartan | 155 | $162,534 |
| JardianceEmpagliflozin | 48 | $67,820 |
| FarxigaDapagliflozin Propanediol | 19 | $29,536 |
| BrilintaTicagrelor | 42 | $21,581 |
| XareltoRivaroxaban | 17 | $20,031 |
| Repatha SureclickEvolocumab | 15 | $11,975 |
| Varenicline Tartrate | 42 | $6,694 |
| Ranolazine ErRanolazine | 24 | $3,523 |
| Metoprolol Succinate | 179 | $1,845 |
| Rosuvastatin Calcium | 114 | $1,729 |
| ClopidogrelClopidogrel Bisulfate | 139 | $1,438 |
| Atorvastatin Calcium | 128 | $1,065 |
| Flecainide Acetate | 31 | $969 |
| Ezetimibe | 39 | $838 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $283 | $210,792195 claims |
| NovartisEntresto | $389 | $162,534155 claims |
| Boehringer IngelheimJardiance | $465 | $67,82048 claims |
| AstraZenecaFarxiga, Brilinta | $663 | $51,11761 claims |
| Johnson & JohnsonXarelto | $351 | $20,03117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Ladson
- Christopher McCartyLadson$13K
- Jason CokerLadson$10K
- Robert BiedermanCharleston$775K
- Darren SidneyNorth Charleston$129K
- Priyanka BhattacharyaCharleston$107K
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
- Gregory EavesAiken$65K
- James SmithCharleston$64K
- Christopher SalmonGreenville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.